Human CCL3/MIP-1 alpha Antibody, R&D Systems™

CCL3/MIP-1 alpha

Polyclonal

Unconjugated

P10147

CCL3

E. coli-derived recombinant human CCL3/MIP-1 alpha Ala27-Ala92 Accession # P10147

100 μg

Primary

Detects human CCL3/MIP-1 alpha in ELISAs and Western blots. In sandwich immunoassays, less than 0.05% cross-reactivity with recombinant human (rh) MIP-1 beta , rhMIP-1 delta , rhMIP-3 alpha , rhMIP-3 beta , and recombinant mouse (rm) MIP-1 alpha is observed. Neutralizes the biological activity of recombinant human CCL3/MIP-1 alpha . In the chemotaxis assay this antibody will also partially neutralize the biological activity of rhMIP-1 beta at a 20 fold higher IgG concentration. It will not neutralize the biological activity of rmMIP-1 beta or rmMIP-1 alpha .

Human

IgG

Western Blot, Immunohistochemistry, Neutralization, ELISA

LYOPH

Western Blot 0.1 ug/mL, Immunohistochemistry 5-15 ug/mL, Neutralization 2-8 ug/mL, ELISA Capture (Matched Antibody Pair) 0.2-0.8 ug/mL

C-C motif chemokine 3, MIP1-(a), AI323804, chemokine (C-C motif) ligand 3, G0S19-1, LD78a, LD78alpha, MIP1 alpha, MIP-1 alpha, Mip1a, MIP-1alpha, MIP1-alpha, PAT 464.1, SCYA3, SIS-beta

Goat

Affinity Purified

RUO

6348

Reconstitute at 0.2 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.